Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a highly malignant human cancer that has increasing mortality rates worldwide. Because CD133(+) cells control tumor maintenance and progression, compounds that target CD133(+) cancer cells could be effective in combating HCC. We found that the administration of chro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Song, Yeonhwa, Kim, Sanghwa, Lee, Hyeryon, No, Joo Hwan, Ryu, Hyung Chul, Kim, Jason, Lim, Jee Woong, Kim, Moonhee, Choi, Inhee, Seo, Haeng Ran
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281429/
https://ncbi.nlm.nih.gov/pubmed/32397206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051193
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados